Ahammune Biosciences Secures $5M for Vitiligo Trials
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
- Latest
- Trending
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Bharat Biotech to amend Covaxin patent to include ICMR as co-owner, rectifying an unintentional omission. Legal documents prepared.
The Pune City police have made a significant breakthrough in a cryptocurrency multi-level marketing fraud case by apprehending the alleged ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.